Messenger RNA brings gene editing a step closer to treat muscular dystrophies

Messenger RNA brings gene editing a step closer to treat muscular dystrophies

Bibliographic Details
Main Author:	John Jacob
Format:	Article
Language:	English
Published:	Elsevier 2022-06-01
Series:	Molecular Therapy: Nucleic Acids
Subjects:	muscular dystrophy base editing gene editing myopathy messenger RNA
Online Access:	http://www.sciencedirect.com/science/article/pii/S2162253122000816

Similar Items

Targeting Duchenne muscular dystrophy by skipping DMD exon 45 with base editors
by: Michael Gapinske, et al.
Published: (2023-09-01)

A novel rabbit model of Duchenne muscular dystrophy generated by CRISPR/Cas9
by: Tingting Sui, et al.
Published: (2018-06-01)

A humanized knockin mouse model of Duchenne muscular dystrophy and its correction by CRISPR-Cas9 therapeutic gene editing
by: Yu Zhang, et al.
Published: (2022-09-01)

Orofacial Manifestations Associated with Muscular Dystrophies: A Review
by: Petros Papaefthymiou, et al.
Published: (2022-03-01)

CRISPR Therapeutics for Duchenne Muscular Dystrophy
by: Esra Erkut, et al.
Published: (2022-02-01)

Prime Editing Permits the Introduction of Specific Mutations in the Gene Responsible for Duchenne Muscular Dystrophy
by: Cédric Happi Mbakam, et al.
Published: (2022-05-01)

Association of Limb-Girdle muscular dystrophy with multiple sclerosis: A case report
by: Mahsa Arzani, et al.
Published: (2018-01-01)

Muscular Dystrophy /
by: Naff, Clay Farris, editor 192865, et al.
Published: (2012)

Role of Immunoglobulins in Muscular Dystrophies and Inflammatory Myopathies
by: Andrea Farini, et al.
Published: (2021-07-01)

Promising therapeutic approaches using CRISPR/Cas9 genome editing technology in the treatment of Duchenne muscular dystrophy
by: Hasan Mollanoori, et al.
Published: (2021-03-01)

Molecular targets to treat muscular dystrophies
by: Jochen Kinter, et al.
Published: (2014-02-01)

Single-swap editing for the correction of common Duchenne muscular dystrophy mutations
by: Andreas C. Chai, et al.
Published: (2023-06-01)

A FRAMEWORK FOR PSYCHOLOGICAL MANAGEMENT OF INDIVIDUALS WITH MUSCULAR DYSTROPHY /
by: Elna Herawati Che Ismail, author 654886, et al.
Published: (2022)

A FRAMEWORK FOR PSYCHOLOGICAL MANAGEMENT OF INDIVIDUALS WITH MUSCULAR DYSTROPHY /
by: Elna Herawati Che Ismail, author 654886, et al.
Published: (2022)

A consolidated AAV system for single-cut CRISPR correction of a common Duchenne muscular dystrophy mutation
by: Yu Zhang, et al.
Published: (2021-09-01)

Adenine base editing of the DUX4 polyadenylation signal for targeted genetic therapy in facioscapulohumeral muscular dystrophy
by: Darina Šikrová, et al.
Published: (2021-09-01)

mRNA-mediated delivery of gene editing tools to human primary muscle stem cells
by: Christian Stadelmann, et al.
Published: (2022-06-01)

A rare case of dystrophinopathy: Duchenne muscular dystrophy–Becker muscular dystrophy intermediate complex
by: Rachna Gulati, et al.
Published: (2022-01-01)

p53-independent DUX4 pathology in cell and animal models of facioscapulohumeral muscular dystrophy
by: Darko Bosnakovski, et al.
Published: (2017-10-01)

Duchenne muscular dystrophy: an historical treatment review
by: Lineu Cesar Werneck, et al.

Limb-girdle muscular dystrophies in India: A review
by: Satish V Khadilkar, et al.
Published: (2017-01-01)

CRISPR-Cas9 editing of a TNPO3 mutation in a muscle cell model of limb-girdle muscular dystrophy type D2
by: Javier Poyatos-García, et al.
Published: (2023-03-01)

Immunohistochemical alterations of dystrophin in congenital muscular dystrophy Alterações imuno-hístoquímicas da distrofina na distrofia muscular congênita
by: Lineu Cesar Werneck, et al.
Published: (1995-09-01)

In vivo genome editing in mouse restores dystrophin expression in Duchenne muscular dystrophy patient muscle fibers
by: Menglong Chen, et al.
Published: (2021-04-01)

Prime editing optimized RTT permits the correction of the c.8713C>T mutation in DMD gene
by: Cedric Happi Mbakam, et al.
Published: (2022-12-01)

Derivation and Characterization of Immortalized Human Muscle Satellite Cell Clones from Muscular Dystrophy Patients and Healthy Individuals
by: Jimmy Massenet, et al.
Published: (2020-07-01)

Double-stranded RNA reduction by chaotropic agents during in vitro transcription of messenger RNA
by: Xijun Piao, et al.
Published: (2022-09-01)

Employment of Microencapsulated Sertoli Cells as a New Tool to Treat Duchenne Muscular Dystrophy
by: Sara Chiappalupi, et al.
Published: (2017-12-01)

Exome sequences versus sequential gene testing in the UK highly specialised Service for Limb Girdle Muscular Dystrophy
by: Elizabeth Harris, et al.
Published: (2017-09-01)

MultiEditR: The first tool for the detection and quantification of RNA editing from Sanger sequencing demonstrates comparable fidelity to RNA-seq
by: Mitchell G. Kluesner, et al.
Published: (2021-09-01)

Surprising genotype expressed as a common limb-girdle muscular dystrophy
by: Liviu Cozma, et al.
Published: (2017-06-01)

Lung function monitoring in patients with duchenne muscular dystrophy on steroid therapy
by: Machado Darlene L, et al.
Published: (2012-08-01)

Prevalence of muscular dystrophy in patients with muscular disorders in Tehran, Iran
by: Khadijeh Hajinaghi Tehrani, et al.
Published: (2018-05-01)

Progressive myopathy in an inducible mouse model of oculopharyngeal muscular dystrophy
by: Ami Mankodi, et al.
Published: (2012-01-01)

Absence of the dystrophin protein in Duchenne muscular dystrophy: effects on transcriptome, proteome and microRNA secretome
by: van Westering, T
Published: (2018)

Myopathy due to HMGCR antibodies in adult mimicking muscular dystrophy associated with cancer and statin exposure – narrative review of the literature – case report
by: Carvalho AAS, et al.
Published: (2018-05-01)

Evidence of Two Novel LAMA2 Variants in a Patient With Muscular Dystrophy: Facing the Challenges of a Certain Diagnosis
by: Stefanie Meyer, et al.
Published: (2022-07-01)

Duchenne muscular dystrophy: Genetic and clinical profile in the population of Rajasthan, India
by: Manisha Goyal, et al.
Published: (2021-01-01)

Errata: Measuring Disease Severity in Duchenne and Becker Muscular Dystrophy
by: Melinda F. Davis, et al.
Published: (2011-05-01)

Histone Deacetylases: Molecular Mechanisms and Therapeutic Implications for Muscular Dystrophies
by: Martina Sandonà, et al.
Published: (2023-02-01)